NASDAQ:HOWL | Income Statement | Werewolf Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$6.16M$13.84M$7.16M-$3.49M$3.67M$0.08$0.0848,597,53448,597,534
2026-03-31$8.18M$13.27M-$13.27M-$261,000.00-$13.53M-$0.28-$0.2848,596,81749,388,181
2025-12-31$6.93M$9.42M-$9.42M$1.04M-$8.38M-$0.16-$0.17810,9941,602,358
2025-09-30$11.63M$15.73M-$15.73M-$644,000.00-$16.37M-$0.36-$0.3645,804,04245,804,042
2025-06-30$13.14M$17.54M-$17.54M-$440,000.00-$17.98M-$0.40-$0.4044,981,74644,981,746
2025-03-31$13.12M$17.99M-$17.99M-$98,000.00-$18.09M-$0.40-$0.4044,827,15944,827,159
2024-12-31$15.73M$20.35M-$20.35M-$52,000.00-$20.4M-$0.46-$0.44384,806473,377
2024-09-30$12.53M$17.12M-$17.12M$451,000.00-$16.67M-$0.38-$0.3843,704,83643,704,836
2024-06-30$15.27M$20.1M-$18.96M$1.71M-$17.25M-$0.40-$0.4343,521,40644,043,184
2024-03-31$12.91M$17.9M-$17.16M$969,000.00-$16.19M-$0.39-$0.3941,607,27941,607,279
2023-12-31$9.65M$14.46M-$12.96M$959,000.00-$12M-$0.33-$0.33311,286311,286
2023-09-30$10.84M$15.15M-$9.25M$966,000.00-$8.29M-$0.23-$0.2335,653,92435,653,924
2023-06-30$9.58M$14.15M-$6.07M$969,000.00-$5.1M-$0.14-$0.1435,557,70135,557,701
2023-03-31$11.71M$16.69M-$12.22M$241,000.00-$11.98M-$0.34-$0.3434,784,68234,784,682
2022-12-31$15.86M$20.46M-$13.18M$1.25M-$11.93M-$0.38-$0.38630,935630,935
2022-09-30$13.07M$17.51M-$12.54M$596,000.00-$11.94M-$0.40-$0.4029,764,00029,764,000
2022-06-30$13.89M$19.12M-$14.97M$378,000.00-$14.59M-$0.53-$0.5327,517,00027,517,000
2022-03-31$10.95M$15.37M-$15.37M$23,000.00-$15.34M-$0.56-$0.5627,393,00027,393,000
2021-12-31$13.4M$17.88M-$17.88M$15,000.00-$17.87M$0.95$0.952,970,0002,970,000
2021-09-30$9.79M$13.8M-$13.8M$37,000.00-$13.76M-$0.51-$0.5127,188,00027,188,000
2021-06-30$7.27M$10.96M-$10.96M$35,000.00-$10.92M-$3.82-$3.8217,750,00017,750,000
2021-03-31$4.82M$7.45M-$7.45M$17,000.00-$7.44M-$83.36-$83.361,229,0001,229,000
2020-12-31$5.29M$7.39M-$7.39M-$10,000.00-$7.4M-$20.05-$20.0550,00050,000
2020-09-30$4.81M$6.05M-$6.05M-$15,000.00-$6.07M-$6.61-$6.61918,000918,000
2020-06-30$3.78M$5.07M-$5.07M$7.32M$2.26M$2.35$0.22947,00010,327,000
2020-03-31$2.76M$3.89M-$3.89M$67,000.00-$3.83M-$4.58-$4.58836,000836,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$44.83M$60.68M-$60.68M-$145,000.00$0.00-$60.82M-$1.32-$1.3346,018,88846,810,252
2024-12-31$56.43M$75.48M-$73.59M$3.08M-$70.52M-$1.63-$1.6343,332,08843,859,664
2023-12-31$41.78M$60.45M-$40.5M$3.14M-$37.37M-$1.05-$1.0535,646,57235,646,572
2022-12-31$53.76M$72.46M-$56.06M$2.25M-$53.81M-$1.86-$1.8628,863,93528,863,935
2021-12-31$35.27M$50.09M-$50.09M$104,000.00-$49.98M-$10.94-$10.9418,455,00018,455,000
2020-12-31$16.64M$22.4M-$22.4M$7.36M-$15.04M-$28.08-$28.081,005,0001,005,000